Glucagon stimulation test for estimating endogenous insulin secretion in dogs

Vet Rec. 2008 Aug 30;163(9):266-70. doi: 10.1136/vr.163.9.266.

Abstract

Fifty-one dogs (27 diabetic dogs, four that had recovered from diabetes and 20 healthy control dogs) were given 0.5 or 1.0 mg glucagon intravenously. Blood samples were taken before the injection and 10 and 20 minutes after it. Samples were analysed to determine C-peptide, insulin and glucose concentrations, and one sample from each dog was analysed for fructosamine. The median (interquartile range) concentrations of C-peptide in the samples taken at 10 minutes were 0.5 (0.3 to 0.8) nmol/l in the control dogs, 0.1 (0 to 0.2) nmol/l in the diabetic dogs, and 0.3 (0.2 to 0.4) nmol/l in the dogs that had recovered from diabetes. Seven of the 51 dogs showed mild adverse reactions after the injection of glucagon.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • C-Peptide / blood
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / veterinary*
  • Dog Diseases / blood
  • Dog Diseases / diagnosis*
  • Dog Diseases / drug therapy
  • Dogs
  • Female
  • Fructosamine / blood
  • Glucagon* / administration & dosage
  • Glucagon* / adverse effects
  • Glucose Tolerance Test
  • Hypoglycemic Agents / therapeutic use
  • Insulin / blood
  • Insulin / metabolism*
  • Insulin / therapeutic use
  • Insulin Secretion
  • Male
  • Treatment Outcome

Substances

  • Blood Glucose
  • C-Peptide
  • Hypoglycemic Agents
  • Insulin
  • Fructosamine
  • Glucagon